Massi P, Patrini G, Rubino T, Fuzio D, Parolaro D
Institute of Pharmacology, Faculty of Sciences, University of Milan, Italy.
Pharmacol Biochem Behav. 1997 Sep;58(1):73-8. doi: 10.1016/s0091-3057(96)00379-6.
We examined whether cannabinoid receptor density changes in the rat spleen after in vivo chronic exposure to cannabinoids. Rats received daily injections of 0.4 mg/kg IP of the synthetic cannabinoid receptor ligand CP-55,940 for 11 days. One h after the last injection on day 11, the rats were killed and spleen coronal sections were processed for receptor binding autoradiography with 10 nM of [3H]CP-55,940 in the absence or presence of unlabeled CP-55,940 (10 microM). Densitometric analysis of the autoradiograms showed significant loss of [3H]CP-55,940 binding of about 42% in chronic cannabinoid-treated, tolerant rats. Our findings indicate that cannabinoid receptors basically present in immune spleen cells are down-regulated by chronic exposure to cannabinoids, suggesting a role in immune modulation and in the impairment of immune function.
我们研究了大鼠在体内长期暴露于大麻素后,其脾脏中大麻素受体密度是否发生变化。大鼠连续11天每天腹腔注射0.4mg/kg的合成大麻素受体配体CP-55,940。在第11天最后一次注射后1小时,处死大鼠,取脾脏冠状切片,在不存在或存在未标记的CP-55,940(10μM)的情况下,用10nM的[3H]CP-55,940进行受体结合放射自显影。放射自显影片的光密度分析显示,在长期接受大麻素治疗的耐受大鼠中,[3H]CP-55,940结合显著丧失约42%。我们的研究结果表明,免疫脾细胞中基本存在的大麻素受体通过长期暴露于大麻素而下调,提示其在免疫调节和免疫功能损害中起作用。